SCHEMBL893567

SCHEMBL893567

CCC1CCNC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12859784 1.00 — —
SCHEMBL10285611 1.00 — —
Hydrochloric Acid SCHEMBL25313407 0.97 — —
Hydrochloric Acid SCHEMBL27152591 0.97 — —
Hydrochloric Acid SCHEMBL25313962 0.97 — —
Methylamine SCHEMBL27804274 0.95 SLC6A1 (0.45) —
Dimethylamine SCHEMBL8326603 0.93 KCNH2 (0.45) —
Dimethylamine SCHEMBL8329721 0.93 KCNH2 (0.45) —
Dimethylamine SCHEMBL8468457 0.93 KCNH2 (0.45) —
SCHEMBL10229124 0.87 SLC6A1 (0.43) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 484 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119663385-A Leveling agent and preparation method thereof, copper electroplating solution and copper electroplating method 广东东硕科技有限公司 2025-03-21 — — CN claimed
CN-119215942-A Dehydrogenation catalyst for preparing aza-aromatic ring, and preparation method and application thereof 中国天辰工程有限公司 2024-12-31 — — CN claimed
WO-2024145505-A1 PYRIMIDINE CARBOXAMIDE COMPOUNDS ACRIVON THERAPEUTICS, INC. (US) 2024-07-04 — — WO claimed
CN-115976586-A Positive and negative pulse electrolytic nickel-tungsten alloy solution, preparation method, electroplating method and nickel-tungsten alloy coating 昆山一鼎工业科技有限公司 2023-04-18 — — CN claimed
CN-109370611-A A method of lysotropic liquid crystal is constructed based on the compound of stearic acid and pyrrolidines derivative 湖北理工学院 2019-02-22 — — CN claimed
EP-2968338-A2 NOVEL USES Intra-Cellular Therapies, Inc. (US) 2016-01-20 — — EP claimed
EP-2956141-A1 NOVEL USES Intra-Cellular Therapies, Inc. (US) 2015-12-23 — — EP claimed
WO-2014145617-A2 NOVEL USES INTRA-CELLULAR THERAPIES, INC. (US) 2014-09-18 — — WO claimed
WO-2014127331-A1 NOVEL USES INTRA-CELLULAR THERAPIES, INC. (US) 2014-08-21 — — WO claimed
US-8771403-B2 Method and system for capturing carbon dioxide and/or sulfur dioxide from gas stream THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2014-07-08 — — US claimed
WO-2011153135-A1 ORGANIC COMPOUNDS INTRA-CELLULAR THERAPIES, INC. (US) 2011-12-08 — — WO claimed
EP-2367428-A1 ORGANIC COMPOUNDS Intra-Cellular Therapies, Inc. (US) 2011-09-28 — — EP claimed
EP-2367430-A1 ORGANIC COMPOUNDS Intra-Cellular Therapies, Inc. (US) 2011-09-28 — — EP claimed
WO-2010065147-A1 ORGANIC COMPOUNDS INTRA-CELLULAR THERAPIES, INC. (US) 2010-06-10 — — WO claimed
WO-2010065152-A1 ORGANIC COMPOUNDS INTRA-CELLULAR THERAPIES, INC. (US) 2010-06-10 — — WO claimed
US-20090318493-A1 Aryl pyrrolidinyl and piperidinyl ketone derivatives and uses thereof ROCHE PALO ALTO LLC 2009-12-24 — — US claimed
CN-1260779-A Epsilon-caprolactam composition and by products UNION CARBIDE CHEMICALS & PROD (US) 2000-07-19 — — CN claimed
EP-0975590-A1 EPSILON CAPROLACTAM COMPOSITIONS AND BYPRODUCTS UNION CARBIDE CHEMICALS & PLASTICS TECHNOLOGY CORPORATION (US) 2000-02-02 — — EP claimed
US-5925754-A REDUCTING BY-PRODUCTS; CHEMICAL INTERMEDIATE FOR NYLON UNION CARBIDE CHEMICALS & PLASTICS TECHNOLOGY CORPORATION (US) 1999-07-20 — — US claimed
WO-1998046564-A1 EPSILON CAPROLACTAM COMPOSITIONS AND BYPRODUCTS UNION CARBIDE CHEMICALS & PLASTICS TECHNOLOGY CORPORATION (US) 1998-10-22 — — WO claimed
Send feedback